AAV Gene Therapy, Small Molecules
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
76
NCT06345703
First-into-human Study of NS-136 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2024
Completion: Feb 28, 2025
Loading map...